Health-care companies rose after strong earnings from one obesity-drug maker. Eli Lilly shares rose after it reiterated its forecast for 32% 2025 revenue growth, amid rising demand for its Zepbound ...
WALL Street stocks mostly rose on Thursday, digesting a round of mixed corporate earnings as markets looked ahead to the January US employment report. Read more at The Business Times.